During the virtual SOLACI-CACI 2021 Congress, the 11th ProEducar Fellows Course—SOLACI’s traditional activity aimed at expanding knowledge and providing didactic tools for all interventional trainees in Latin America—was held. The course was a huge success: almost 1500 people accessed the Andreas Gruentzig Virtual Room where the activity took place. Furthermore, over 35 prestigious speakers from all...
SOLACI-CACI 2021 | Day 3: Main Arena Auditorium
✔️ Day 3 Completo, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨🏫 Program: 00:05 – CBS@SOLACI-CACI Session 01:43:26 – CCI@SOLACI-CACI Session 03:07:38 – Oral presentation – Structural III 04:32:21 – Oral presentation – Coronary III 06:01:39 – SAC FAC@SOLACI-CACI Session 👉 SESSION I: Functional Mitral Regurgitation: New Horizons for Transcatheter Therapy 👉 SESSION II: Medical Treatment...
SOLACI-CACI 2021 | Watch Again the Session from Grupo MIL-SOLACI-CACI on Gender Opportunities in Interventional Cardiology
✔️ Watch again the session “The MIL Group/SOLACI/CACI/WAO Gender Opportunities in Interventional Cardiology” delivered during SOLACI-CACI 2021. The session, conducted by Dr. Carla Agatiello -Director of the Latin American Group of Interventionist Women (MIL) from SOLACI-, revolved around gender matters in the field of interventional cardiology. In this regard, it focused on job placement data...
SOLACI-CACI 2021 | SCAI Session
✔️ SCAI Session (Society for Cardiovascular Angiography and Interventions) in the SOLACI-CACI 2021 Congress. 👨🏫 Program: 00:03 – STEMI: Approach to Left Main Culprit – Dr. Timothy Henry. 15:38 – Gender Disparities in STEMI – Dr. Cindy Grines. 29:52 – Optimal DAPT Post Complex PCI – Dr. George Dangas. 47:01 – PCI or CABG for...
SOLACI-CACI 2021 | TCT II Session: Structural Heart Interventions
✔️ TCT Session in the SOLACI-CACI 2021 Congress. 👨🏫 Program: 02:44 – Future of TAVR – Martin B. Leon 36:27 – Future Developments in Trans-Catheter Mitral Valve Replacement – Juan F. Granada 01:02:53 – Interventional Heart Failure – Dan Burkhoff 👉🏻 Chairperson: Aníbal Damonte & Jorge Belardi 👉🏻 Digital Moderator: Matías Sztejman 👉🏻 Panelists:...
SOLACI-CACI 2021 | SAC-FAC Session
✔️ Watch again the complete SAC-FAC Session in the SOLACI-CACI 2021 Congress. 👨🏫 Program: – SESSION I: Functional Mitral Regurgitation: New Horizons for Transcatheter Therapy 01:06 – Optimal Medical Treatment in Patients with Cardiac Failure and Mitral Regurgitation – Florencia Renedo 12:12 – Ultrasonographic Screening of Patients for Endovascular Therapy – Walter García 25:43 –...
ESC 2021 | Updated European Society of Cardiology Guidelines for the Management of Valvular Heart Disease
Early intervention in asymptomatic valvular heart disease, age recommendations to decide between TAVR and surgery for aortic stenosis, and a push in favor of transcatheter repair in secondary mitral regurgitation are some of the new modifications to the European Society of Cardiology (ESC) Guidelines for the Management of Valvular Heart Disease. This new document was...
SOLACI-CACI 2021 | International Sessions with the Most Renowned Societies Worldwide
INTERNATIONAL SESSIONS WITH THE MOST RENOWNED SOCIETIES WORLDWIDE Appealing sessions on the most relevant current topics in interventional cardiology will be at the forefront of a virtual, interactive event you do not want to miss! Save the date: August 2-6, 2021 Register now for FREE Learn more about the international joint sessions featured in...
Differences in American and European Atrial Fibrillation Guidelines
The recent publication of the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) guidelines provided an important update on multiple aspects of the management of atrial fibrillation (AF). However, these guidelines differ in terms of management and recommendation levels. As it might be expected, most differences arose in intermediate cases—both guidelines...
EuroPCR 2021 | Ultrathin Struts Consolidate as Next DES Development
According to this recent meta-analysis of randomized studies, ultrathin strut devices are associated with lower rates of target vessel failure vs. 2nd generation drug eluting stents (DES). This advantage was driven by fewer clinically justified reinterventions. This study was published in the European Heart Journal and simultaneously presented at EuroPCR 2021 Scientific Sessions. Ultrathin struts...